- October 1, 2014Reviews mTOR inhibition and mammalian longevity, arguing the current evidence best fits lifespan extension mainly through cancer suppression, with symptomatic…
- December 1, 2014A randomised, observer-blind, placebo-controlled trial in 218 adults aged 65 and over reports that six weeks of low-dose RAD001 improved…
- July 1, 2018A phase 2a randomised, placebo-controlled trial in 264 adults aged 65 and over reports that six weeks of a low-dose…
- March 1, 2025A clinical review of geroscience: which ageing pathways can be modified, and how much human evidence currently supports each intervention.
- May 1, 2025An open-label phase 1 pilot trial in ten older adults with mild cognitive impairment or early Alzheimer's dementia: eight weeks…
- December 1, 2025A single-arm, open-label pilot trial in 14 people with early Alzheimer's disease: six months of weekly oral rapamycin was tolerated,…